Adverse Childhood Experiences and Substance Use Disorders: What a Kenyan Hospital Study Shows
Adverse childhood experiences in addiction treatment are highly prevalent among adults in a Kenyan psychiatric hospital. This study found strong associations between specific childhood adversities and current substance use patterns. Understanding these…
Cannabinoid Clinical Trials: Mental Health & Substance Use
Cannabinoids mental health studies highlight that current evidence does not firmly establish cannabinoids as effective primary treatments for most mental health or substance use disorders. Adverse effects were commonly reported, emphasizing clinical…
Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis
This study examines the cannabis use disorder psychiatric risk profile compared to other substance use disorders. Findings indicate lower rates of schizophrenia, depression, and psychotic disorders in cannabis users. These insights inform clinical risk…
Understanding Genetic Nurture in Substance Use Transmission
This research highlights genetic nurture substance use, showing how parental genetics and environment influence offspring risk. It reveals dual pathways of inheritance and environment in substance use disorders. Clinicians can better assess family risk…
Review of Cannabinoid Clinical Trials for Mental Health Treatment
This cannabinoid clinical trials mental health treatment review summarizes current evidence on cannabinoids' efficacy and safety for mental health disorders. The review highlights consistent adverse effects reported in trials. Careful clinical monitoring…
Why People Use Cannabis Predicts Whether Use Becomes Harmful, Review Finds
A 2024 narrative review highlights that cannabis use motives, particularly coping motives, strongly predict cannabis-related problems and disorder. Medical and coping motives overlap, complicating clinical assessment. Understanding cannabis use motives…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
This scoping review synthesizes randomised controlled trial evidence medicinal cannabis for treating mental health and substance use disorders. The review addresses previous limitations in study design and quality. It provides clinicians with a clearer…
Cannabinoids for Mental & Substance Use Disorders: Evidence
Current evidence on cannabinoids for substance use disorders shows limited and inconsistent benefits. Safety concerns remain a consistent finding across clinical trials. The efficacy of cannabinoids for mental and substance use disorders remains…
Endocannabinoid System Research: Cannabis for PTSD & SUDs
Endocannabinoid system research cannabis PTSD meta-analysis reveals trauma-focused treatments remain effective for individuals using cannabis. People with PTSD and co-occurring substance use disorders show comparable outcomes regardless of cannabis use.…
The efficacy and safety of cannabinoids for mental and substance use disorders
This review examines cannabinoids for mental substance use disorders evidence, focusing on their efficacy and safety. Mental health and substance use disorders are common reasons for cannabinoid use. The study highlights the need for careful clinical…
